References
Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes-Boyau O, Martin-Lefevre L, Jabaudon M, Mimoz O, Coudroy R, Ferrandière M, Kipnis E, Chevallier S, Mallat J, Robert R, ABDOMIX Group (2015) Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med 41:975–984. doi:10.1007/s00134-015-3751-z
Quenot JP, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC, Castelain V, Barraud D, Cousson J, Louis G, Perez P, Kuteifan K, Noirot A, Badie J, Mezher C, Lessire H, Pavon A (2013) The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care 17(2):65. doi:10.1186/cc12598
Riché FC, Dray X, Laisné MJ, Matéo J, Raskine L, Sanson-Le Pors MJ, Payen D, Valleur P, Cholley BP (2009) Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care 13(3):R99. doi:10.1186/cc7931
Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C (2009) Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301(23):2445–2452. doi:10.1001/jama.2009.856
Conflicts of interest
MA, SLC, and CR received an unrestricted research grant from ESTOR s.p.a. that funded part of the EUPHAS study published in the JAMA, and MA is a member of the steering committee of the EUPHRATES study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Antonelli, M., Cutuli, S.L. & Ronco, C. Polymyxin B hemoperfusion in septic shock: just look at the evidence!. Intensive Care Med 41, 1731–1732 (2015). https://doi.org/10.1007/s00134-015-3931-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-015-3931-x